Friday, November 24, 2017

Brexit becomes real for pharmaceuticals

As Chris Stirling, head of global life sciences for KPMG, the consultancy, puts it: “For Amsterdam, it's a windfall beyond just the regulatory jobs.” His clients, he says, “consider being close to the EMA as an important consideration in location strategy, so the EMA location should attract private sector ...
Delivered by KPMG Today (@KPMG_TO)
Article continues here
Follow @KPMG_TO on Twitter to get latest updates